This case is a composite drawn from clinical encounters over many years. Names, ages, occupations, timelines, and identifying circumstances have been changed. No individual patient is depicted. The clinical pattern has been preserved.

She arrived with five years of records arranged in chronological order.

Her routine blood work had repeatedly been called normal. The symptoms had not followed the report. Sleep remained broken. Fatigue survived the weekend. Pain moved without settling into a diagnosis.

She had already done the usual rounds.

Primary care had ruled out obvious disease. A specialist had reviewed one part of the picture. A functional clinic had ordered a wider panel and built a large supplement protocol around the findings.

She had followed all of it.

That was the first fact I almost misunderstood.

Physicians are trained to notice nonadherence. We ask whether the patient filled the prescription, changed the diet, attended therapy, or used the device. When the patient does everything asked, we tend to move on.

Adherence reassures us.

Her adherence should not have.

The plan required food tracking, supplement timing, exercise, recovery work, repeated testing, sleep monitoring, and several daily practices. Each part had a rationale. Together, they occupied the remaining space in a life already built around responsibility.

She had not failed treatment.

Treatment had become another environment in which she could prove she needed nothing.

I asked what had disappeared from her life during the years she had been managing her health.

She first answered with tasks she had stopped because of fatigue. Then she named the quieter losses. Unmeasured time. Work done with her hands. The ability to eat without evaluating the meal. A morning that did not begin with a score.

Those losses were not side notes. They changed how I read the case.

The relevant clinical question was no longer whether each recommendation could be defended. Most of them could.

The question was whether their combined workload exceeded her biological and practical capacity.

The concept is established in minimally disruptive medicine. Treatment adds work. Patients have finite capacity. When the work of care exceeds that capacity, a theoretically correct plan can become unlivable.

Her response had been to create more capacity through effort.

That response had protected her for years. It also concealed the point at which adaptation became cost.

We simplified.

We kept the interventions with a clear purpose. We removed what had accumulated without changing the ground. We stopped treating every measurable variation as an instruction. We tracked sleep, recovery, function, and whether parts of her life began returning.

The goal was not fewer interventions as an ideology.

The goal was a plan that left enough person to recover.

Later, she told me she had begun making things again. She did not present this as a health outcome. It was not in the laboratory portal.

It was still one of the clearest signs that the plan finally fit the subject.

This case note is the companion to Saturday’s essay, The Patient Who Was Excellent at Being Unwell.

Case Notes are short stories from the exam room, the moments that change a visit. Subscribing is free, and it's how the next one finds you.

If someone you love is working harder at getting well than at living, send this to them.

Share

What has your health plan quietly pushed out of your week? Tell me in the comments. I read them.

Leave a comment

Dr Shiv Kumar Goel is an internal medicine and functional medicine physician and founder of Prime Vitality Care in San Antonio. Across 25 years in hospitals, intensive care, and functional medicine, he has studied the gap between what medicine can measure and what patients actually live through. He writes Healing the Split and is the author of the forthcoming book Healing the Split: When Your Biology Is Fighting Your Biography.

She placed a manila folder on the desk before she sat down.

The reports were separated by year. The medications were listed by dose. The supplements had their own page, including when she took them and whether they needed food.

She had tracked her meals to the gram. She had tracked her sleep on two devices. She had completed the breathing program, bought the cold-plunge tub, and stayed with the elimination diet longer than anyone had asked.

She was not careless with her health.

She was excellent at being unwell.

That sentence may sound cruel. I mean the opposite.

She had become exceptionally skilled at performing every task illness and healthcare placed before her. She arrived prepared. She remembered dates. She followed instructions. She did not miss appointments or exaggerate symptoms.

Her doctors called her compliant.

She was also exhausted, waking through the night, hurting in places that changed, and losing contact with the person she remembered being.

Nothing in the folder explained that last part.

Medicine has a word for patients who follow the plan: adherent. We usually mean it as praise. Medication taken correctly. Appointments kept. Dietary instructions followed. Monitoring completed.

Those things matter. A treatment cannot help if it is never used.

But adherence answers only one question. Did the patient carry out the plan?

It does not answer whether the plan fit the patient. It does not tell us what carrying it out required. It does not tell us what had to disappear from her life so the plan could remain intact.

That is where this patient had been missed.

She had visited conventional physicians first. Her routine laboratory work was reassuring. Her thyroid was within range. Her glucose did not announce diabetes. Her blood count did not provide a clean explanation for the fatigue.

She was told to improve her sleep and reduce stress.

The advice was not wrong. It was too small.

She then entered the wellness world, where the same suffering produced the opposite conclusion. Instead of nothing being wrong, almost everything became a target. More testing. More flagged values. More supplements. More rules about food, light, temperature, timing, exercise, and recovery.

Some of the biology behind those recommendations was legitimate. Circadian timing matters. Nutrition matters. Movement matters. Breathing can change autonomic state.

But a true mechanism does not make every intervention appropriate for every person.

One system gave her reassurance without an explanation. The other gave her an explanation so large that managing it became a second occupation.

Neither system asked the same basic question.

What is this plan costing this particular person?

Evidence-based medicine is built from groups. That is its strength. A well-conducted trial can show whether an intervention helps more people than it harms, on average, under defined conditions.

The person across the desk is not an average.

She arrives with a particular childhood, family structure, metabolism, hormonal ground, financial reality, sleep history, caregiving load, and way of reading danger. She also arrives with a body that has adapted to those conditions for years.

Two patients can receive the same instruction and undergo different exposures.

“Exercise five days a week” may restore one person and deplete another. A detailed food plan may create useful structure for one patient and turn every meal into an examination for another. A wearable may reveal a pattern. It may also convert sleep into another performance she believes she can fail.

Same recommendation. Different body.

This is not an argument against guidelines. It is an argument for finishing the work guidelines begin.

The field of minimally disruptive medicine uses a useful distinction between workload and capacity. Workload includes everything illness and treatment ask a person to do. Capacity includes the physical, cognitive, social, financial, and environmental resources available to do it.

When workload repeatedly exceeds capacity, the patient does not simply become “noncompliant.” The plan becomes incompatible with the life in which it must operate.

My patient created a different problem. She increased her effort every time the plan exceeded her capacity.

She did not drop the task. She dropped herself.

That pattern looked admirable from the outside. It had probably been admired for most of her life.

She managed work, family, appointments, meals, refills, exercise, and everyone else’s emergencies. If a plan failed, she assumed she had not executed it correctly enough. She responded by becoming more precise.

The precision concealed the cost.

Her body had been adapting to sustained demand through the HPA axis, autonomic nervous system, immune signaling, and metabolism. These systems are designed to preserve function when circumstances require more from us. That adaptation is called allostasis.

Allostasis is not disease. It is protection.

The cost appears when the demand does not end. A response built for mobilization remains active, returns too often, shuts down too slowly, or becomes too depleted to respond normally. The accumulated biological price is called allostatic load.

That helps explain why the same life does not produce the same body in two people.

The event is not the whole exposure. The exposure also includes what the event meant, what came before it, what resources were available afterward, and what the person had learned they were permitted to need.

This patient had learned to answer strain with competence.

Her body followed.

It mobilized when she asked. It kept her functional. It carried one more responsibility, then another. It protected the life she had built until protection itself became expensive.

The body does not malfunction. It escalates.

The question that changed our visit was not which panel had been missed.

I asked what had quietly disappeared while she was becoming so good at taking care of herself.

She did not answer immediately.

Then she described several ordinary things she no longer did. Nothing dramatic. Time with her hands. Time without measurement. A part of the week that did not produce anything for anyone.

Her treatment plan had many instructions for the body. It contained almost no room for the person living in it.

That distinction matters clinically.

A plan can improve biomarkers while reducing function. It can lower weight while taking muscle. It can improve a sleep score while making the patient afraid of a bad night. It can produce flawless adherence while consuming the remaining capacity required for recovery.

None of those outcomes proves the intervention was wrong.

They prove that the subject must remain visible.

I began removing tasks.

Not because sleep, nutrition, movement, and medication had stopped mattering. Because the plan had to stop recreating the same condition we were trying to treat: a life in which she could never be finished.

We kept what had a clear purpose. We questioned what had been added by momentum. We watched function, sleep, recovery, and the return of ordinary desire, not only whether she completed the protocol.

The work became less impressive.

It also became more honest.

Months later, the detail she mentioned was not a laboratory value. She had begun making things with her hands again. It was something she had not done for years.

She did not describe it as recovery.

She said she recognized herself.

Evidence told us which interventions might help a patient like her. Only the subject could tell us whether those interventions still served the life she was trying to recover.

The folder remained organized.

It was no longer the most alive thing she carried into the room.

This essay uses a composite drawn from clinical encounters over many years. Names, ages, occupations, timelines, and identifying circumstances have been changed. No individual patient is depicted. The clinical pattern has been preserved.

Sources: May, Montori and Mair, “We need minimally disruptive medicine,” BMJ, 2009. Shippee and colleagues, “Cumulative complexity,” Journal of Clinical Epidemiology, 2012. McEwen, “Protective and damaging effects of stress mediators,” New England Journal of Medicine, 1998.

Every essay here starts in the exam room. Subscribing is free, and it's how the next one finds you.

If you know someone carrying a folder like hers, send this to them.

Share

What quietly disappeared from your week while you were busy taking care of your health? Tell me in the comments. I read them.

Leave a comment

Dr Shiv Kumar Goel is an internal medicine and functional medicine physician and founder of Prime Vitality Care in San Antonio. Across 25 years in hospitals, intensive care, and functional medicine, he has studied the gap between what medicine can measure and what patients actually live through. He writes Healing the Split and is the author of the forthcoming book Healing the Split: When Your Biology Is Fighting Your Biography.

Choose one behavior other people praise in you.

It may be answering every message. Training through exhaustion. Skipping lunch because the work matters. Saying yes before you have checked what the yes will cost.

Do not change it yet.

For seven days, write down four things when the behavior appears: what happened just before it, what you predicted would happen if you stopped, what your body was doing, and what the behavior cost you six hours later.

Keep the observation plain. Tight jaw. Missed meal. Faster pulse. Irritability at home. Waking at three. No interpretation is required.

At the end of the week, ask one question:

If the behavior involves prescribed treatment, nutrition for a medical condition, exercise restrictions, or medication, do not change it from a newsletter exercise. Bring the pattern to the clinician responsible for that care.

This practice goes with last week’s essay, The Day Discipline Became a Symptom.

Practices here are small, specific, and meant to be done, not admired. Subscribing is free, and it's how the next one finds you.

If someone you know is praised for the habit that is wearing them down, send this to them.

Share

Which behavior did you choose? Tell me in the comments. I read them.

Leave a comment

Dr Shiv Kumar Goel is an internal medicine and functional medicine physician and founder of Prime Vitality Care in San Antonio. Across 25 years in hospitals, intensive care, and functional medicine, he has studied the gap between what medicine can measure and what patients actually live through. He writes Healing the Split and is the author of the forthcoming book Healing the Split: When Your Biology Is Fighting Your Biography.

This case is a composite drawn from clinical encounters over many years. Names, timelines, occupations, and identifying circumstances have been changed. No individual patient is depicted. The clinical pattern has been preserved.

She said it once while describing the abdominal pain.

“I kept going.”

She said it again when I asked how long she had followed the diet.

Eight months.

No garlic. No onions. No wheat. No beans. No restaurant meals unless she had chosen the menu first.

She had started a low-FODMAP diet after years of bloating and unpredictable bowel symptoms. At first, it helped. Her abdomen felt quieter. The improvement was real.

Then the temporary restriction became the permanent plan.

She had never been taken through systematic reintroduction. Nobody had asked which foods actually caused symptoms. Nobody had helped her find the broadest diet her body could tolerate.

Instead, she became better at restriction.

She carried food to family gatherings. She declined dinner invitations. She read labels until eating required more vigilance than hunger.

“I kept going,” she said again.

I asked what happened when she tried a food outside the plan.

She did not describe the symptom first. She described the fear.

That changed the visit.

The diet was not wrong. The sequence had stopped halfway.

The American Gastroenterological Association describes the low-FODMAP approach in three phases: restriction for no more than four to six weeks, reintroduction, and personalization. The American College of Gastroenterology recommends only a limited trial, and grades the evidence as very low quality.

Restriction had given her useful information. It was never meant to become her identity.

We did not tell her to eat everything. We did not dismiss the symptoms as anxiety. We treated the fear and the bowel symptoms as different information.

She began with one food, one amount, on one ordinary day. Then she watched what happened.

Not what she feared would happen. What happened.

The goal was not perfect digestion. The goal was a life in which digestion did not make every decision.

At the next visit, she had added several foods back. Some still caused symptoms. Others did not. The list was smaller now.

So was the fear.

Near the end, she said it once more.

“I kept going.”

This time, she meant something different.

This case note is the companion to Tuesday’s essay, The Day Discipline Became a Symptom.

Case Notes are short stories from the exam room, the moments that change a visit. Subscribing is free, and it's how the next one finds you.

If someone you love has been on a “temporary” diet for months, send this to them.

Share

Have you ever kept going with a plan long after it stopped helping? Tell me in the comments. I read them.

Leave a comment

Dr Shiv Kumar Goel is an internal medicine and functional medicine physician, founder of Prime Vitality Care in San Antonio. Across 25 years in hospitals, intensive care, and functional medicine, he has studied the gap between what medicine can measure and what patients actually live through. He writes Healing the Split and is the author of the forthcoming book Healing the Split: When Your Biology Is Fighting Your Biography.

She handed me a list of forty-seven foods she no longer ate.

Not foods she disliked. Not foods she had casually decided to avoid. These were foods she had removed carefully, one after another, while trying to make her gut behave.

Her colonoscopy was normal. Her endoscopy was normal. The celiac panel, stool cultures, and basic inflammatory markers were unremarkable.

She had been told she had irritable bowel syndrome. She was advised to reduce stress, identify her triggers, and try a low-FODMAP diet.

None of that was unreasonable.

The low-FODMAP diet has evidence behind it. For some people with IBS, reducing fermentable carbohydrates can decrease bloating, pain, and unpredictable bowel movements. The American College of Gastroenterology recommends a limited trial.

Limited matters.

The diet was designed to move through stages. Restrict for a defined period. Reintroduce foods systematically. Then personalize the long-term diet around what the individual can actually tolerate.

She had completed the first stage with extraordinary discipline.

She had never reached the other two.

At first, removing food helped. A difficult evening followed a large meal, so she ate less. Wheat seemed connected to bloating, so wheat went. Then dairy. Then onions, garlic, apples, legumes, and most meals she had not prepared herself.

Each removal created a little less uncertainty.

It also created a smaller life.

She stopped going to restaurants unless she had studied the menu first. She carried her own food to family gatherings. She declined dinners because explaining the list felt harder than staying home.

Her gut was slightly quieter.

Everything around it had narrowed.

From the outside, this looked like discipline. She followed instructions. She tracked symptoms. She resisted temptation. She did not complain about the inconvenience.

Inside the body, something else was happening.

The plan had stopped being an experiment and become a system of vigilance. Every meal was screened for danger. Every sensation became evidence. Every flare justified another restriction.

The treatment was no longer only treating the symptom.

It had begun to resemble it.

This is where medicine often misreads the compliant patient. We are trained to worry about the person who does not follow the plan. We ask whether they understood it, could afford it, or were ready to change.

We are less suspicious of perfect adherence.

The chart says the patient is compliant. The clinician feels reassured. The patient receives praise for doing exactly what was asked.

But adherence is not proof that a treatment still fits.

Sometimes it is proof that the person has become very skilled at overriding themselves.

That distinction matters because two patients never receive the same intervention in the same body.

One brings a post-infectious gut. Another brings years of disrupted sleep. Another brings food insecurity from childhood, a caregiving load, a sensitized pain system, or a nervous system that learned early that control was safer than uncertainty.

The written recommendation may be identical.

The exposure is not.

Evidence tells us what tends to happen across groups of people. It helps us estimate benefit, risk, and probability. Without it, medicine becomes opinion dressed as confidence.

But evidence-based medicine was never meant to erase the subject.

In 1996, David Sackett and his colleagues defined it around decisions for individual patients. The model joined the best available research with clinical expertise. Later formulations made the patient’s values and circumstances explicit.

The evidence was one part of the encounter.

The person was always supposed to remain inside it.

That sounds obvious until the average and the individual separate.

The guideline can be right. The patient can follow it. The outcome can still be wrong for that person.

That is not evidence failing.

It is evidence being used without enough attention to the life receiving it.

In her case, the question was not whether food affected her gut. It did. Some sensitivities were real and worth respecting.

The better question was whether all forty-seven foods were still the problem.

So we stopped treating the list as settled fact.

We looked at sequence. What had happened before each restriction? How long had it been tested? Was the reaction reproducible? What else was happening that week? How had she slept? What conversation had occurred before the flare? What happened when the same food appeared on a quieter day?

The pattern was uncomfortable.

Food mattered. But the week often mattered more.

Her symptoms rose before difficult Mondays. They intensified during family illness. They softened on days when her body was not already carrying five other demands.

That did not make her symptoms psychological.

The HPA axis changes gut motility, secretion, blood flow, and pain signaling. The enteric nervous system and the brain communicate continuously. A colonoscopy can rule out visible structural disease. It cannot show what the gut does during traffic, grief, vigilance, or a conversation the body has learned to anticipate.

Her normal scope was important.

It was not the whole story.

We did not replace one rigid protocol with another. We did not order ninety tests. We did not give her a larger supplement stack.

We widened the experiment.

She began reintroducing one food at a time. Slowly. She tracked symptoms beside sleep and stress, not food alone. She walked after dinner because movement helped without turning recovery into another performance.

Six weeks later, she had not reclaimed forty-seven foods.

She had reclaimed four.

Lentils on a Tuesday. Oats on a Saturday morning. A small apple, twice. Then dinner at her sister’s house, with nothing packed separately in a bag.

Four foods do not look dramatic in a medical record.

A life becoming wider does.

I asked what had helped most. She did not name the reintroduction schedule. She did not name the walk or the food log.

She said someone had finally explained what her gut was doing.

Her gut had not been lying to her. It had been reporting from the place where food, immunity, memory, and stress meet.

She had been disciplined because she wanted her life back.

The work began when discipline stopped being the only thing we measured.

Case disclosure: This essay is drawn from an approved composite in the manuscript. Names, timelines, clinical details, and identifying circumstances have been changed. No individual patient is depicted. The clinical pattern is preserved.

I write Healing the Split for people whose tests came back normal and who still don't feel normal. Subscribing is free, and it's how the next essay finds you.

If someone you love is living off a list like hers, send this to them.

Share

Have you ever followed a plan perfectly and watched your life get smaller? Tell me in the comments. I read them.

Leave a comment

Dr. Shiv Kumar Goel is an internal medicine and functional medicine physician based in San Antonio, where he founded Prime Vitality Care. With over 25 years of experience spanning hospital critical care and functional medicine, he specializes in the gap between what medicine can measure and what patients truly live through. He is the author of the forthcoming book Healing the Split: When Your Biology Is Fighting Your Biography and writes the Healing the Split newsletter.

Five minutes, a piece of paper, and three lines you write for nobody but yourself

I don’t open the chart first anymore. I ask two questions, and most of what I need is usually sitting inside the answers. Here’s how to ask them at your own kitchen table.

Five minutes. Something to write with. Do it alone.

Write one line naming the thing that’s been bothering your body lately. Not the diagnosis, if you have one.

The sensation itself, in whatever words you’d use if nobody medical were listening.

Where it sits. What it feels like when it’s worst.

Write a second line answering this. What was happening in your life in the months before it started.

Don’t reach for the dramatic answer if the true one is quieter.

A promotion counts, and so does a move, and so does the year where nothing happened on paper while everything was happening underneath.

Most people start by saying nothing, and then keep talking for a while. Let yourself keep talking.

Write a third line answering this one. Where have you felt this exact bracing before.

Whose reaction does yours remind you of.

Let whatever name or face shows up, show up. You don’t have to do anything with it.

Then read the three lines once, out loud if you’re alone, and put the paper down.

That’s the whole practice.

It should feel unfinished. The patient I wrote about last week answered the third question with one sentence about her mother and the phone ringing at dinner, and that sentence turned out to be the eight months.

Two things before you try it.

This doesn’t replace a workup, and it isn’t meant to.

A symptom that’s new or changing or getting worse belongs in front of a doctor first.

And if what surfaces on that third line is bigger than five minutes, that isn’t the exercise failing. That’s real, and it belongs with someone trained to sit with it.

Keep the paper. Bring it to your next appointment and put it in your pocket.

Hand it over or don’t. Most patients already know. Almost nobody gets asked.

Subscribe below if you want the next one, and write back if you actually try this, because I read those.

Subscribe now

Dr. Shiv Kumar Goel, MD, is an internal and functional medicine physician in San Antonio. Founder of Prime Vitality Care and author of the forthcoming Healing the Split: When Your Biology Is Fighting Your Biography.

She kept a legal pad next to her in every meeting. Not for notes. For her stomach. Writing gave her hands something to do besides press against her side under the table.

She isn’t a patient. She’s a composite. I’ll call her Nora. If you’re one of mine and something here lands close, it isn’t about you. It means I’…

Read more

Five specialists in two and a half years. None of them asked the right question. The answer was in a sentence she said almost smiling.

Maya’s husband called ahead of the appointment.

He was a chiropractor, methodical and devoted. For two and a half years, he did what people do when they love someone and can’t fix them. Reading everything ever written about every diagnosis she had been given, in case understanding it would somehow stop it.

By the time they sat in front of me, he had become, out of sheer desperation and love, a walking encyclopedia of her chart.

He brought the binders. The MRI discs. The lab printouts organized by date. The skin biopsy reports. The neurology notes. The rheumatology workup. The ophthalmology exam. Dermatology. GI. All of it.

I told him I would look at everything he had brought. But first I wanted to just talk with her.

Forty minutes. No chart open. No binder. Nothing between us but a question and whatever she was willing to say.

What five specialists had not asked

Two and a half years earlier, her father had died. Then, just days later, her brother. Two losses arriving almost simultaneously, before she had finished absorbing the first one. Grief stacked on grief, with no pause between them, and no room in her life for either.

A few weeks later, she developed severe pain in a tooth. The kind of acute physical emergency the body produces when emotional pain has nowhere else to go. She ended up in a dental chair.

After the procedure, an infection. Her dentist prescribed clindamycin. Days later, a rash appeared across her body. Then headaches. Then shooting pain down one side of her face. Then severe problems with the eye on the same side. Pain, blurred vision, light sensitivity that would not resolve.

Neurology got her first. CT and MRI were negative. EEG was negative. The episodes came in clusters that didn’t fit a clean seizure pattern, didn’t fit a clean migraine pattern, didn’t fit anything with a tidy billing code. She was given pain medication and gabapentin and sent forward.

Dermatology performed a skin biopsy. Inflammatory dermatitis. A real finding, a real name. But a description of what the skin was doing, not an answer to why. Steroids helped temporarily. The rash kept returning.

Ophthalmology found nothing structural. Prescribed new glasses.

By the time rheumatology saw her, her ANA was elevated. But none of the other markers were consistent with any recognizable autoimmune pattern. Lupus lacked this. Sjögren’s lacked that. Vasculitis didn’t quite fit.

The rheumatologist documented what was honest: autoimmune disease of uncertain etiology, pending further workup.

A name that meant: something is happening, and we cannot find the box it belongs in.

The sentence that completed the map

Before I opened a single file in Maya’s chart, I asked two questions that none of the prior notes contained the answer to.

What was happening in your life in the months before the dental procedure?

She told me about her father. Then her brother. Then the tooth pain that arrived in the middle of all that grief.

How have you been sleeping?

She had not slept well since her father died. Her husband confirmed: she barely ate, could not keep much down. He had stopped pushing food because watching her try to eat and then vomit was harder than accepting the liquid calories she would tolerate.

And then, almost as an aside, almost smiling when she said it:

I’ve always had anxiety. I got that from my mother. She was always at the edge. I grew up watching her, and I suppose I caught the habit.

The map was complete.

What I was looking at was not five separate conditions affecting five separate organ systems. It was one person whose losses had never been processed. Whose nervous system had been running in threat-response since childhood. Inherited, trained, passed forward from a mother who was always at the edge.

Her immune system, already depleted by grief and sleeplessness and barely adequate nutrition, had been pushed past its threshold by an antibiotic that disrupted her already-fragile gut microbiome.

The rash. The facial pain. The eye involvement. The elevated ANA without a clean pattern.

This was not a disease without a name. It was a body without a witness.

A body without a witness will eventually find a way to testify.

What gets passed down without being said

Maya had mentioned her mother almost in passing.

I caught the habit. The way people mention things they have carried so long they no longer feel their weight.

But she was describing something researchers have spent two decades documenting with increasing precision.

Rachel Yehuda’s group at Mount Sinai studies Holocaust survivors and their children. They’ve found measurable epigenetic marks on the glucocorticoid-receptor gene passed down to offspring. Those children never experienced the original trauma. They inherited the calibration anyway.

Brian Dias and Kerry Ressler at Emory conditioned male mice to fear a specific odor, then found that their offspring, who had never been exposed to that conditioning, showed heightened sensitivity to that exact smell. The transmission was mediated by methylation changes in sperm DNA.

A 2025 study on Syrian refugee families found specific DNA methylation changes associated with war-related violence in people whose only exposure to that violence had been through their parents and grandparents.

The experience of the previous generation had been encoded in the next generation’s nervous system before that generation was born.

Maya did not catch anxiety the way you catch a cold. She inherited a calibration. A nervous system doesn’t ask where the fear came from. It just runs the program it was handed. A stress-response threshold set by her mother’s unresolved load, passed forward in the most intimate way possible. Written into her biology before she had language for any of it.

What looked like a body breaking down was actually a body running a program older than she was.

What the labs finally said

I ordered what I needed to confirm what I already understood.

Severely dehydrated. Profoundly anemic. Iron, B12, folate, and vitamin D critically depleted. Her four-point salivary cortisol curve was almost completely flat. An adrenal system that had been running at emergency capacity for so long it had lost the ability to cycle. Testosterone negligible. Estrogen low. Progesterone barely detectable. Her secretory IgA, the immune system’s first line of defense in the gut and mucosal tissues, suppressed in exactly the pattern you see when the stress response has been running without interruption for a prolonged period.

Her basic labs had been fine. Her biology was not.

We started IV hydration immediately. Parenteral replacement of every depleted nutrient. A short course of low-dose hydrocortisone with DHEA. Box breathing twice a day. Not as a wellness gesture. As a direct physiological intervention to activate the vagal brake and signal to the nervous system that the emergency level could come down.

A few days later she called. She could feel the beginning of facial pain and shooting sensations returning.

I knew immediately what it was. Herpes zoster. Shingles. The varicella virus that had been dormant in her nervous system since childhood, held quiet by a functioning immune system. But her immune system had not been functioning. It had been depleted for months. The virus had been waiting for exactly this opening.

The label had been wrong from the start. What she had was zoster, progressing along a nerve pathway, in a woman whose immune system had been too suppressed by grief, malnutrition, and adrenal exhaustion to mount a response.

Valacyclovir. Nutritional rebuilding. Bi-est, progesterone, testosterone. The body finally getting back what the years of running on empty had quietly taken from it.

Two months later, she called me from Peru. She had gone to visit her surviving brother. She was eating. She was sleeping. The pain was gone. The rash was gone. The fog had lifted.

I feel like I got a new life, she said.

Call it what you want. What she got was the life her body had been trying to return to since the day her father died, since the grief had nowhere left to land.

What I want you to know

If you have been told repeatedly that your labs are fine, and your body is clearly telling you otherwise, your body is not lying. The instrument is incomplete.

And if you grew up inside a nervous system that was always at the edge, that calibration is not a personality. It is a physiology. It is also reversible, in the sense that the body never stops trying to return to the life it was built for.

The five specialists who saw Maya were not wrong. They were positioned, each of them, in their particular window. None of those windows opened onto her father. Or her mother’s nervous system. Or the dental chair, the place where the grief had finally found a doorway out.

The body keeps its own record. Sometimes the work of getting well is finding the physician who knows how to read it. And learning, slowly, how to read it yourself.

References

Yehuda R, Daskalakis NP, Bierer LM, et al. Holocaust exposure induced intergenerational effects on FKBP5 methylation. Biol Psychiatry. 2016;80(5):372-380.

Dias BG, Ressler KJ. Parental olfactory experience influences behavior and neural structure in subsequent generations. Nat Neurosci. 2014;17(1):89-96.

Mulligan CJ, Quinn EB, Hamadmad D, et al. Epigenetic signatures of intergenerational exposure to violence in three generations of Syrian refugees. Sci Rep. 2025;15(1):5945. doi:10.1038/s41598-025-89818-z.

Shiv Kumar Goel, MD, is an internal medicine and functional medicine physician in San Antonio, with over two decades in hospital and critical care medicine. He is the founder of Prime Vitality Care and TimeVitality, and the author of the forthcoming book Healing the Split: When Your Biology Is Fighting Your Biography. He writes the Substack of the same name at healingthesplit.com. All patient details have been altered; cases are composites drawn from twenty years of clinical practice.

William did not come in to talk about his heart.

He came for a men’s-health visit — erectile dysfunction, some fatigue, nothing dramatic. He was 55, stressed, tired, and quietly worried that he no longer felt like himself.

His primary care doctor had recently told him his cholesterol looked normal and his risk was low. He believed it. His numbers looked fine: LDL-C 108 mg/dL, HDL-C 52 mg/dL, triglycerides 118 mg/dL, total cholesterol 182 mg/dL.

But in midlife men, erectile dysfunction is often an early vascular clue. Men with ED carry higher future rates of cardiovascular disease, stroke, and death than men without it (2019 meta-analysis; Circulation: Outcomes analysis). None of that made him a cardiac patient. It did mean the routine panel had left the real question open.

So we looked further, at two markers that refine risk when a standard panel comes up short (2026 ACC/AHA dyslipidemia guideline).

Erectile Dysfunction Is Often Vascular Data, Not Just “Performance”

When a midlife man arrives with erectile dysfunction, the system tends to file it as a local problem — performance, mood, testosterone. The cohort data argue otherwise. Across prospective studies, men with ED run a higher future risk of cardiovascular events, coronary heart disease, stroke, and death, even after adjusting for the usual risk factors, with relative risks commonly between 1.3 and 1.6 for major outcomes (prospective cohort analyses; umbrella reviews). ED tends to arrive early, ahead of an event, not after it (narrative reviews).

The signal is strongest in William’s group. Risk runs higher in intermediate-risk men and in younger men in their 40s and 50s — the very men most likely to be reassured by a normal cholesterol and a quick calculator (mortality-focused meta-analysis). For them, ED is often the first sign the endothelium is falling behind, years before a conventional event.

That reshapes what an ED visit is for. A man in his 50s with new erectile dysfunction, central weight gain, and a family history of early heart disease deserves more than a phosphodiesterase inhibitor and a testosterone level. He deserves an honest cardiovascular look: blood pressure, fasting glucose and insulin, ApoB and Lp(a), and, in the right case, a coronary calcium score (advanced lipoprotein markers).

Not every case of ED needs a cardiac workup. But in a midlife man, it should stop being filed as a purely local complaint when his vascular system may be telling the truth first.

Why “Normal Cholesterol” Can Mislead

Cholesterol does not move through the blood on its own. It rides inside lipoprotein particles — and in many people, the number of atherogenic particles predicts arterial risk better than the cholesterol concentration does. A 2025 systematic review of discordance studies put ApoB ahead of both LDL-C and non-HDL-C as a risk marker (2025 systematic review).

LDL-C tells you how much cholesterol sits inside LDL particles. ApoB estimates how many atherogenic particles are carrying it. When the two agree, the standard panel works. When they diverge, the panel can read reassuring while particle burden runs high (recent discordance analyses).

Two men can share an LDL-C. One carries it in relatively few particles; the other spreads it across many more, often alongside insulin resistance or higher triglycerides. The cholesterol number matches. The arterial exposure does not.

So the sharper question is not whether your cholesterol is normal. It is how many atherogenic particles you carry, and what you inherited.

What ApoB and Lp(a) Add

Cholesterol is not the villain. It builds cell membranes, steroid hormones, bile acids, vitamin D, and the structure of nerves. Lipid therapy is not trying to erase it. It is trying to lower the number of ApoB-containing particles that can lodge in the artery wall (current dyslipidemia guidance).

Every atherogenic particle — LDL and VLDL remnants alike — carries a single apolipoprotein B. So ApoB counts the particles most able to do damage. LDL-C is the cholesterol in circulation; ApoB is how many potentially atherogenic vehicles are on the road.

William’s ApoB came back at 102 mg/dL — more particle burden than his routine panel implied, and above the roughly 80 mg/dL considered optimal for a man carrying added cardiovascular risk. His LDL-C looked acceptable. His particle count was not.

Then there was Lp(a), or lipoprotein(a). It is largely inherited, stays stable across life, and never appears on a standard panel unless someone asks for it. William’s measured 68 mg/dL, above the 50 mg/dL mark used to flag elevated risk. Guidelines now support measuring it once in adulthood, because it sharpens risk in ways nothing else on the panel can (ACC; AHA Lp(a) initiative).

His cholesterol panel read reassuring. His risk picture did not.

How to Actually Use ApoB and Lp(a)

Advanced lipids earn their place only when they change the decision in the room.

ApoB matters most when the story hints at discordance — a borderline LDL-C paired with higher triglycerides, central weight, prediabetes, or a strong family history of premature heart disease. In those patients, particle number and cholesterol concentration have often parted ways, and an ApoB moves the risk from uncertain to actionable (ApoB discordance literature).

What you do with it depends on context. For primary prevention without known disease, current guidelines set LDL-C goals under 100 mg/dL across low-to-intermediate PREVENT risk, and under 70 mg/dL at high risk. ApoB refines those calls, flagging people whose particle burden outruns their LDL-C, especially at an ApoB of 120 mg/dL or higher, or when several risk enhancers cluster (2026 multisociety guideline summary).

Lp(a) works differently. You measure it once, not repeatedly (National Lipid Association summary). An elevated level raises baseline risk for atherosclerotic events and aortic valve disease, argues for tighter LDL-C and ApoB targets, and justifies screening across the family, since the trait is inherited.

A borderline-risk man with a strong family history of early heart attack and a high Lp(a) is not the same patient as one with identical calculated risk and a normal Lp(a). In the first, the threshold to start a moderate-intensity statin, tighten blood pressure, and push harder on lifestyle is easier to cross.

For patients, the move is simple: if the numbers and the family story do not match, ask whether ApoB and Lp(a) have ever been checked. Your biology may be carrying information the basic panel never recorded.

What the Evidence Shows

Three points hold up.

ApoB catches risk that LDL-C misses when the two diverge, and in that situation it is the more accurate marker. Elevated Lp(a) is not a lab curiosity — it is an independent, causal driver of atherosclerotic disease and aortic valve disease, which is why guidelines now call for measuring it once in every adult. And lowering ApoB-containing lipoproteins reduces events in the right patients, particularly higher-risk people already on standard therapy (current guideline summaries).

None of that means every person with a normal LDL-C and a high ApoB needs aggressive treatment tomorrow. In primary prevention, baseline risk still governs. The USPSTF recommends a statin for adults 40 to 75 with at least one risk factor and a 10-year risk of 10% or more, and a more selective approach between 7.5% and 10% (USPSTF recommendation).

A normal panel can hide real risk, and treatment intensity still has to fit the whole patient. Both are true.

How the Guidelines Think About “Borderline” Risk

For people without known heart disease, the hard calls sit in the middle — not the low-risk 25-year-old or the high-risk 68-year-old, but the 45-year-old whose cholesterol looks fine on paper and whose calculator says “borderline.”

The USPSTF keeps it simple: for adults 40 to 75 without cardiovascular disease, a statin when there is at least one risk factor and a 10-year risk of 10% or more, and a more selective approach from 7.5% to 10%. Past 76, the evidence runs out (USPSTF recommendation).

The 2026 ACC/AHA multisociety guideline uses the newer PREVENT equations instead of the older pooled cohort equations, and layers risk enhancers on top (2026 guideline press release). PREVENT gives 10-year and 30-year estimates for adults 30 to 79 and sorts risk into low, borderline, intermediate, or high.

The enhancers tilt the call: family history of premature disease, chronic inflammation, high triglycerides, metabolic dysfunction, kidney disease, high ApoB, and elevated Lp(a).

Take a man at borderline or intermediate PREVENT risk who also carries a high Lp(a), a higher ApoB, central weight, and a sibling who had a heart attack at 52. The guideline frame supports treating him earlier and more assertively — a statin, tighter lipid targets, and often a coronary calcium score to see whether atherosclerosis is already underway (JAMA Cardiology editorial).

The rule is not that everyone at 7.5% gets a statin. It is that baseline risk, risk enhancers, family story, and advanced lipids belong in one conversation. When they line up toward higher risk, waiting for the first event stops being a neutral choice.

Why the Same “Normal” Doesn’t Mean the Same Thing

If two people can share an LDL-C and not a risk, the reasons are worth naming.

Insulin resistance, visceral fat, and higher triglycerides push the body toward more atherogenic particles without moving LDL-C much. Genetics shape both Lp(a) and the tendency toward discordance. Even the measurement matters — LDL-C is usually calculated, not measured directly, and the estimate drifts when triglycerides run high (ApoB review literature).

Your neighbor’s normal panel is not a verdict on your arteries.

It is also why both halves of modern medicine miss this. Routine care underuses ApoB, so hidden risk goes unmeasured. Aggressive longevity and functional practices overcorrect, treating every off-range biomarker as a disease. Neither reflex helps. Better measurement, then better interpretation, does.

HDL shows the trap. A low HDL is a useful marker, but raising it with drugs has not reliably reduced cardiovascular events in trials (systematic review and meta-regression). Low HDL is a reason to look upstream, not a target to chase.

Advanced Lipids Are Tools, Not Identity Labels

Advanced lipids can clarify risk. They can also be abused.

Conventional care errs by omission — never ordering ApoB or Lp(a) in the very patients whose stories point straight at discordance or inherited risk. The wellness and longevity world errs the other way, ordering enormous panels and treating every flagged line as its own disease.

The pattern is familiar. A patient arrives having had LDL particle number, oxidized LDL, Lp-PLA2, small dense LDL, and a fistful of proprietary scores measured. He has been told everything is wrong and put on a stack of supplements, a restrictive diet, and a schedule of expensive repeat testing. Strip it back, and the two signals that mattered were a high ApoB and a high Lp(a) — reachable with far fewer tests, and enough to guide real decisions about statins, lifestyle, and family screening (ApoB; Lp(a) consensus guidance).

The cost of over-testing is not only money. It turns biology into identity. Patients start describing themselves as oxidized-LDL types or particle-number types, even where those markers were never tied to outcomes the way ApoB and Lp(a) are. Risk becomes a brand. The nervous system burns its energy tracking panel changes instead of tracking whether the person is actually moving toward safer ground.

The honest use of advanced lipids is narrower. Order ApoB and Lp(a) when they will change a decision. Read them against guideline thresholds, family history, and the body in front of you. Then fold them back into the question that governs the rest of care: what, in this particular person, is happening that the standard instruments have only half seen?

What I Tell Patients in Clinic

When the routine panel looks acceptable but the picture does not, two measurements help: ApoB and Lp(a). ApoB estimates current particle burden. Lp(a) reveals inherited risk the standard panel will never show, and once in adulthood is enough (current guidance).

It earns its place when the numbers do not fit the person — a family history of early heart disease, central weight gain, prediabetes, higher triglycerides, or a vascular clue like midlife ED. There, a normal LDL-C is not the end of the conversation. It is where the better question starts.

When treatment is warranted, the answer is not always the most aggressive drug on the shelf. In primary prevention, baseline risk, tolerance, and preference still count, and shared decision-making belongs there.

William understood the science. He understood that his routine panel had not told the whole story. He still chose to wait, and I did not push him.

A more accurate risk picture does not force every patient to the same decision. It does force us to stop mistaking normal cholesterol for a finished cardiovascular assessment.

Questions to Bring Into the Visit

If your cholesterol looks fine but something still nags at you, these are quetions worth bringing to your next visit — 

1. “My cholesterol came back normal, so how do you actually know how likely I am to have a heart problem someday?” This nudges your doctor toward a real risk estimate with tools like PREVENT instead of a rough guess.

2. “Should we check my ApoB? With my triglycerides, my weight, and heart disease in my family, I’m not sure the regular cholesterol test tells the whole story.” ApoB can show particle risk a standard panel misses.

3. “Has anyone ever checked my Lp(a)? Heart trouble runs in my family, and I heard it’s a one-time test.” Current guidance supports checking it once in adulthood.

4. “If I’m kind of on the fence, what would make you lean toward starting a statin — and what would make you say let’s wait?” The USPSTF thresholds are a good anchor for that talk.

5. “Would one of those heart calcium scans actually tell us whether I need medication right now?” In in-between cases, the score often moves the decision one way or the other.

6. “Besides pills, what could I actually do that would move my numbers — my ApoB, my blood pressure, my weight?”

7. “If my ED might be an early warning for my heart, how do we take it seriously without going overboard on tests?”

That last one holds the ground the evidence supports: neither brushing the symptom off nor turning it into a sales pitch, but reading it as data.

If the panel looks fine but the picture does not, the goal is not more tests. It is the right two — and a more honest conversation about what they mean.

Enjoyed this breakdown?

The Life Beyond Labs series examines one health question at a time — without the hype in either direction.

For deeper clinical essays on what medicine often misses and what patients actually feel, subscribe to my Substack: Healing the Split

I publish there first, for readers who want more than a test result.

About the Author

Dr. Shiv Kumar Goel is a board-certified physician in internal medicine, functional medicine, and aesthetic medicine based in San Antonio, Texas. He brings over two decades of clinical experience to the intersection of conventional diagnostics and the lived reality of patients whose suffering resists easy measurement.

He is the author of What Medicine Misses and Patients Feel (forthcoming) — a clinically grounded, human account of the gap between what standard medicine can see and what patients actually experience.

To follow his work: drshivgoel.com To reach him directly: contact@drshivgoel.com

Patient details including name, age, timeline, and identifying circumstances have been changed. William is a composite drawn from clinical encounters over many years of practice. No individual patient is depicted or identifiable.

One day you wake up. Same walls. Same ceiling. Same people.

But something has shifted.

The place you have been calling home — you see it now as a cage.

Not because it changed. Because you did.

This is the moment no one warns you about. They talk about the breakthrough. The awakening. The turning point. They make it sound like freedom arrives with applause.

It doesn’t.

It arrives as a quiet, disorienting terror. The walls look the same. Your name is still on the door. The people inside still love you in the only way they know. But you can see the bars now. And once you see them, you cannot unsee them.

I have sat with this in my own life. I have watched it in patients.

The physician who has been practicing for twenty years and realizes she has been practicing someone else’s medicine. The son who has run the family business for a decade and wakes one morning knowing he was never meant to be there. The woman who has kept everything together and suddenly cannot explain why the keeping together feels like it is slowly killing her.

Good labs. Bad life. There’s a reason.

The reason is not weakness. It is not ingratitude. It is not crisis.

It is biology finally saying what biography never let you say.

The ones who feel caged do not become more caged when they start to see clearly. They were always caged. The clarity is not the problem. The clarity is the beginning.

The guards at the door — the ones who tighten their grip the moment you start asking questions — they are not your enemies. They are loyal to the only architecture they have ever known. Your seeing threatens their certainty. That is not malice. That is fear wearing the mask of care.

The reformers — the ones who arrive with the language of liberation and offer you a newer, cleaner cell — they are the most dangerous. Learn to feel the difference between the one who opens the door and the one who just moves it.

Here is the harder truth.

The prison was not built by your enemies. It was built by people who lived inside one too. They handed it to you as shelter. They called it home because it was the only home they had.

They created the split. You carried it without knowing.

This is what breaks open when I sit with a patient who is doing everything right and still feels like a stranger in their own life. It is not their failure. It is an inherited structure. The body is doing what biography asked of it — loyally, faithfully, until it cannot anymore.

The body does not malfunction. It escalates.

Not everyone who sees the prison wants to leave.

I want to be honest about that.

[Patient composite — all identifying details modified]

A man I’ll call Dev is in his late fifties. Spent his career in a demanding field that ran on hierarchy and protocol — you followed the chain, you did not question it. He came in a few months ago for insomnia. His wife had just passed. Over two decades together. No children.

I have known him for a while.

He is not a man who questions the architecture around him. He followed the rules. He built the life he was told to build. His wife, in her own quiet way, agreed with everything — which did not give him a mirror. It gave him an echo.

Now she is gone. And for the first time in his life, no one is telling him what to do next.

He told me his life is over.

He is on antidepressants. He is seeing a therapist. We are doing what the situation calls for.

But sitting with him, I heard something underneath the insomnia, underneath the grief. He is not lost because she died. He is lost because the warden just left.

The prison is all he has ever known. The walls are the only grammar he has for the word home.

I did not try to show him the door.

Some people are not ready for it. Some people, at this point in a life, need the walls to still be there. To take that from him — in the name of liberation — would be its own kind of violence.

I listened. I renewed his prescription. I told him to come back.

That is also medicine.

Out beyond ideas of wrongdoing and right doing,

there is a field.

I’ll meet you there.

— Rumi

So how do you leave, when you are the one who is ready?

Not by breaking harder. The more force you bring to the bars, the more the structure tightens around the force. That is not a metaphor. The HPA axis reads threat. The nervous system braces. The biology follows. You cannot heal in a body that is still bracing for impact.

You leave the way water leaves — through the crack that was always there.

The way of the whisper, not the shout. The inner knowing that was never lost. Only silenced. Only buried under the noise of the biography you were handed.

You never needed the map. You have the GPS built inside each fabric of yours.

The world outside does not reward you for leaving. No parade. No applause. For a while, the ones you love most will not understand. They may resist. They may grieve the version of you that stayed.

That is not your failure.

It is the natural consequence of becoming more clearly yourself in a space that was built around a smaller version of you.

I don’t know where you are reading this. Maybe at midnight. Maybe in the car after a long day when the house felt too quiet and too full at the same time. Maybe on a Sunday night when the weight of the week ahead feels like it belongs to someone else’s life.

But I know this.

The fact that you can see it — really see it — is not the problem.

It is the way.

The body has been waiting a long time. This is the first time you agreed to look.

Dr. Shiv Kumar Goel is a board-certified physician practicing internal, functional, and aesthetic medicine in San Antonio, Texas. He is the author of the forthcoming book Healing the Split: When Your Biology Is Fighting Your Biography. He writes at healingthesplit.com.

Move more. Eat real food. Sleep. Don’t smoke. All true. All necessary. And it’s also where most people stop.

The patients who age slowly — the ones whose bodies look a decade younger than their charts — almost always do a few quieter things the headlines skip. None of these replace strength training or a decent diet. They sit on top of the basics, cost almost nothing, and target the parts of aging we usually ignore until they’re already gone: balance, metabolic flexibility, and the biological signal you can actually track.

These are the three I do myself, every morning, and prescribe to patients every week.

1. I Stand on One Leg While I Brush My Teeth

Why this matters

We spend enormous energy worrying about heart disease and almost none worrying about balance — until a fall happens. That is backwards.

Falls are among the most life-altering events in later life. They are a leading cause of injury-related death in older adults, and more than that, they are often the starting point for a cascade: a fracture, then immobility, then muscle loss, then the loss of independence that was never supposed to come this soon. What makes this particularly frustrating is that balance is not a fixed trait. It is a trainable skill, at any age. The nervous system and the muscles that hold us upright respond to practice the same way any other physical capacity does — if you ask them to work, they maintain. If you never ask, they quietly decline.

What the research actually shows

The one-leg balance test looks simple. It is not.

A 2022 study in the British Journal of Sports Medicine followed 1,702 middle-aged adults and found that those who could not hold a 10-second one-leg balance had an 84% higher risk of all-cause mortality over the following decade, even after controlling for age, sex, BMI, and underlying health conditions. That is not a minor signal. An 84% higher risk of death from failing a test that takes ten seconds to administer — a test that costs nothing, requires no lab, and can be done in a clinic hallway.

A separate longitudinal cohort study from the UK’s MRC National Survey of Health and Development followed over 2,000 adults from age 53 to 68. It found that those with consistently low balance scores at age 53 — before most chronic disease had declared itself — had more than three times the risk of recurrent falls by age 68 compared to those who could sustain balance for 30 seconds. That is a 15-year window between the signal and the consequence.

Balance is also one of the few measures that captures neuromuscular aging — the slow loss of coordination between the brain’s motor signals and the muscle’s capacity to respond — before it becomes visible. By the time a patient tells me they feel unsteady, the decline has already been building for years. The balance test catches it earlier, and earlier is when it’s still reversible.

What I do

Two minutes per leg, every morning, while I brush my teeth. I stand near the counter at first. Eyes fixed on one point. Breathing normal. I don’t rush it. Once 30 seconds feels easy, I increase difficulty: close the eyes for a few seconds to remove visual stabilization, or count backwards from a hundred to add cognitive load. That dual-task balance challenge mimics the real-world scenario — navigating a parking lot while thinking about something else — which is exactly when most falls happen.

If you haven’t done this in a while, start with eyes open and a hand available. The goal in week one is just to notice how it feels. Most people are surprised by how much harder it is than they expected.

2. I Take a 10-Minute Walk Right After I Eat

Why this matters

A great deal of what we call “aging” is accumulated metabolic wear — the slow damage that compounds from years of repeated blood sugar excursions after meals. Every time blood glucose spikes steeply and stays elevated, it drives a wave of low-grade inflammation, accelerates glycation of proteins and tissues, and adds to the biological debt the body has to service.

The most effective intervention I know for blunting those spikes is not a supplement. It costs nothing. It does not require a prescription. It is gentle movement in the thirty minutes after eating.

What the research shows

The data here is consistent across multiple populations and study designs.

A 2025 randomized crossover trial published in Scientific Reports found that a 10-minute walk taken immediately after a glucose load significantly reduced peak postprandial glucose and total glucose area under the curve, compared to both sitting and to a 30-minute walk taken 30 minutes after eating. The timing mattered as much as the duration. Walking immediately after the meal, while the gut was still absorbing glucose, produced a more effective glucose reduction than a longer walk taken later.

Earlier studies confirmed the same pattern in people with type 1 diabetes and in healthy adults, showing that post-meal walking reduces glucose excursions more meaningfully than pre-meal or fasted-state walking. The mechanism is relatively direct: muscle contraction during light movement increases glucose uptake by skeletal muscle through an insulin-independent pathway — GLUT4 transporter translocation — meaning blood sugar moves into cells whether or not insulin levels are high. This is particularly relevant for people whose insulin sensitivity is already declining, which describes most adults past their mid-thirties.

Over a year, over ten years, over two decades — smoothing those daily post-meal spikes is one of the most underrated things a person can do for their metabolic age.

What I do

Ten minutes, within thirty minutes of finishing a meal. No particular pace. No targets. I walk outside when I can; around the building when I can’t. After lunch is the highest-yield if someone only does it once a day — the post-lunch glucose response is often the largest of the three daily meals, and it hits during the hours when energy typically dips and people reach for coffee.

I tell patients: the meal ends, the walk begins. Not because you have time for it — make it the boundary. It takes the same time as checking your phone after eating. And it doubles as a stress reset, which is its own metabolic benefit.

3. I Track One Number So Aging Stops Being Invisible

Why this matters

Biological aging is quiet. It accumulates slowly, compounds for years, and rarely announces itself with a dramatic warning. Most of the patients I see with advanced metabolic dysfunction, elevated cardiovascular risk, or early chronic disease had normal labs five years earlier. Not because the labs were wrong — but because the labs they ran weren’t measuring what was actually moving.

The patients who change their trajectory share one behavior: they made aging visible. They picked one number that actually tracked their biological age — not their birthday — and they watched it move.

When aging is invisible, it is easy to postpone. When it has a value, it becomes a conversation you can have with yourself every three months.

What the research shows

hs-CRP (high-sensitivity C-reactive protein)

hs-CRP is a marker of systemic inflammation — the kind of sustained, low-grade inflammatory activity that damages blood vessels, impairs insulin signaling, accelerates cellular aging, and raises the risk of cardiovascular disease, diabetes, and all-cause mortality. A 2025 longitudinal cohort study in Archives of Gerontology and Geriatrics found that cumulative hs-CRP levels — even those below the traditional “elevated” threshold of 10 mg/L — were independently associated with increased all-cause mortality, mediated partly through blood pressure, fasting glucose, and uric acid. In other words, chronically elevated inflammation, even when it looks “normal” on a single lab draw, leaves a biological invoice.

The ACC/AHA guidelines identify hs-CRP ≥2.0 mg/L as a cardiovascular risk enhancer. In my practice, I watch trend lines, not single values. A patient whose hs-CRP was 0.8 two years ago and is now 1.7 is telling me something. They are not yet in “elevated” territory. They are moving toward it, and movement is the whole point.

ApoB (Apolipoprotein B)

ApoB is a better measure of cardiovascular aging risk than LDL cholesterol in most patients. Every atherogenic particle in the blood — including small dense LDL, IDL, and VLDL — carries exactly one ApoB molecule. Total ApoB therefore tells you how many atherogenic particles are circulating, not just their cholesterol content. Studies including the AMORIS study with more than 175,000 participants have shown ApoB to be a stronger predictor of fatal myocardial infarction than LDL-C. For a patient in their forties whose LDL looks acceptable but whose particle count is high, ApoB is the number that catches the risk that LDL misses.

Grip strength

This one surprises people.

Grip strength is one of the single most well-replicated predictors of all-cause mortality in medicine. A 2007 longitudinal study in The American Journal of Medicine followed nearly 5,000 adults for 30 years and found that grip strength in the highest quintile at baseline was associated with roughly half the mortality risk of those in the lowest quintile — a relationship that held for heart disease, stroke, and pneumonia, and remained significant after 20 years of follow-up. A 2022 meta-analysis of 121,116 adults across 29 countries confirmed the same dose-response relationship: every 5 kg increase in grip strength was associated with a 14% reduction in all-cause mortality and cardiovascular death.

What grip strength is measuring, indirectly, is the overall integrity of the neuromuscular system — the same system that governs balance, fall risk, recovery from illness, and the capacity to maintain independence into later life. It is not measuring hand strength alone. It is measuring how much biological reserve the entire system has.

You can measure it at home with a hand dynamometer for less than twenty dollars. You can recheck it every three months. It is more informative than most things on a standard annual panel.

What I do

I start patients on one number. Not four, not seven. One — the one that is most likely to be telling their particular story.

For someone with strong family history of cardiovascular disease or whose LDL looks acceptable but whose metabolic picture is unclear, I start with ApoB. For someone with vague fatigue, joint symptoms, or autoimmune risk, I start with hs-CRP. For someone whose primary concern is energy, blood sugar, and weight, I add fasting insulin alongside HbA1c — the two together reveal insulin resistance far earlier than HbA1c alone.

For patients who are skeptical about labs, I start with grip strength. Cheap. Immediate. Deeply predictive. Recheck it in 90 days. They always come back curious about the number.

Then we schedule. Every three to six months for labs. More often for home measures. Not obsessively — the goal is trend, not perfection. What gets measured tends to get managed. And what gets managed, over a decade, tends to matter.

A Word on What These Three Have in Common

None of these are glamorous. There is no device to buy, no subscription to start, and nothing to swallow.

They share a structural logic: they are all small signals sent to the body on a daily or weekly basis that remind it to stay capable of something. Balance practice tells the nervous system that proprioception and neuromuscular coordination still matter. Post-meal walking tells the metabolic system that it does not have to absorb glucose passively. Tracking a number tells the clinician — and the patient — that biological aging is being watched, not just assumed.

The patients who age well in my practice are not the ones doing the most. They are the ones doing the right things, consistently, before they needed to. Before the fall. Before the diagnosis. Before the number that was quietly moving finally made itself undeniable.

The goal was never just to add years. It was to make the years we add feel younger.

That is the real work of longevity medicine — and most of it still starts before breakfast.

Key Supporting Studies

Balance and fall prevention:

• Bergland A, et al. One-leg balance is an important predictor of injurious falls in older people. Age Ageing. 1997;26(2):123–130. [PMID: 9180669]pubmed.ncbi.nlm.nih

• Blodgett JM, et al. One-Legged Balance Performance and Fall Risk in Mid and Later Life. Am J Prev Med. 2023;64(3):e87–e95. [PMID: 36470757]sciencedirect+1

• Araújo CG, et al. Successful 10-second one-legged stance performance predicts survival in middle-aged and older individuals. Br J Sports Med. 2022;56(17):975–980.bjsm.bmj

• Cruz-Jentoft AJ, et al. Balance as an indicator of neuromuscular aging. Med News Today. 2024.medicalnewstoday

Post-meal walking and glucose:

• Shiraiwa T, et al. Positive impact of a 10-min walk immediately after glucose intake on postprandial glycemic control. Sci Rep. 2025;15:23161.nature+2

• Colberg SR, et al. The effect of walking on postprandial glycemic excursion in patients with type 1 diabetes. Diabetes Care. 2012. [PMID: 22875231]pubmed.ncbi.nlm.nih

hs-CRP and all-cause mortality:

• Tian Y, et al. Cumulative hs-CRP and all-cause mortality in middle-aged and elderly adults. Arch Gerontol Geriatr. 2025;135:105861. [PMID: 40354683]pubmed.ncbi.nlm.nih

• Blankenberg S, et al. Mortality risk prediction of high-sensitivity CRP. PMC8863282. 2022.pmc.ncbi.nlm.nih

ApoB and cardiovascular risk:

• Sniderman AD, et al. Age and Cardiovascular Risk Attributable to ApoB. Circulation. 2016. [PMC5121475]pmc.ncbi.nlm.nih

• Bonifacio E, et al. Significance of ApoB in elderly as predictive factor of cardio-cerebrovascular complications. Diabetes Res Clin Pract. 2009.sciencedirect

Grip strength and mortality:

• Sasaki H, et al. Grip strength predicts cause-specific mortality in middle-aged and elderly persons. Am J Med. 2007;120(4):337–342. [PMID: 17398228]pubmed.ncbi.nlm.nih

• López-Gil JF, et al. Longitudinal association of handgrip strength with all-cause and cardiovascular mortality. Exp Gerontol. 2022.sciencedirect

• del Pozo Cruz B, et al. Handgrip strength with all-cause and cancer mortality: 28 countries. Age Ageing. 2022;51(5):afac117. [PMID: 35639798]pubmed.ncbi.nlm.nih

• Taekema DG, et al. Prognostic value of handgrip strength in people 60+. Geriatr Gerontol Int. 2016. [PMID: 26016893]

About the Author

Dr. Shiv Kumar Goel, MD, is a internist and functional medicine physician in San Antonio, Texas. Trained at the Icahn School of Medicine at Mount Sinai, he is the founder of Prime Vitality Care and blends internal, functional, and integrative medicine to help patients align their health with their daily rhythms. He writes about longevity, stress physiology, and the reconnection of mind, body, and spirit in modern medicine.

She came in tired but matter-of-fact, the kind of fatigue you learn to carry without advertising. Mid‑forties, mid‑career banker, the sort of person whose life is built around other people’s anxieties about money. For three years, she had been waking up at 3:40 a.m. most nights—so consistently that she stopped needing the clock. It felt like her nervous system had set an alarm she hadn’t agreed to.

By the time she reached me, she had already done what most high-functioning patients do: supplements, devices, tracking. Melatonin. Magnesium. A sleek ring grading her sleep as if it were a quarterly report. The more she watched the numbers, the more anxious she became. Her scores dipped, and the story she told herself hardened: “I’m just a light sleeper. This is probably my age and my job catching up with me.”

On the surface, nothing was alarming. No major mood symptoms, no significant alcohol, no shift work. She went to bed around 10:30 p.m. She did “the right things” most sleep handouts mention. But when I asked her to walk me through the four hours before bed, not the five minutes before lights out, a different pattern appeared.

Dinner was often at 9 p.m., heavy and late, after a day of grazing and coffee. Lights in the kitchen and home office stayed bright and overhead long after dark, the kind of light that tells your brain it’s noon. The evening was full of unresolved tasks: emails half-drafted, deals half-closed, lists held silently in her head. Bedtime was not the end of the workday; it was where the workday got replayed.

I didn’t give her a new pill. Instead, we turned the focus to those four quiet hours before bed. We moved dinner earlier, aiming for at least a three‑hour window before she got under the covers—not as a rule to obey, but as an experiment in what happens when her body isn’t busy sorting out a late, heavy caloric load overnight. We lowered the angle and intensity of light: overheads off after sunset, warm lamps on, screens dimmed. And we created a small ritual for her mind: a handwritten list of unfinished tasks, followed by fiction that had nothing to do with banking, self‑improvement, or sleep.

Within a week, the 3:40 a.m. wake‑ups stopped. Not tapered, not “slightly better”—they simply didn’t show up. She still had stressful days. Markets still moved. But she no longer had the sense that her body was staging a nightly intervention. What changed wasn’t her diagnosis or her willpower; it was how food, light, and thought were arranged in the last part of the day.

Cases like hers keep pulling me back to a simple, unglamorous question: “Tell me about your evening.” Not the checklist of sleep hygiene tips, not the brand names of devices—but the lived, ordinary hours when your physiology is quietly deciding what kind of night you’re going to have. We talk a lot about insomnia as if it begins at bedtime. More often, it begins with the life that leads up to it

I think about her on the nights when my own patients tell me they’ve “tried everything” for their sleep. What they usually mean is that they’ve tried everything they can buy. The harder work is rearranging the hours that don’t look like medicine at all—the late dinner, the overhead light, the mental to‑do list we mistake for productivity. If your body keeps waking you at the same time night after night, it may not be punishing you; it may be pointing to the part of your day you’ve decided is non‑negotiable.

Healing the Split is a reader-supported publication. If you’d like more essays on sleep, stress physiology, and the stories patients tell themselves about being “high‑functioning” while exhausted, you can subscribe for free or choose a paid subscription to support the work. Paid readers help me carve out protected time for this kind of slow, narrative medicine—clinic stories that don’t fit in a 15‑minute visit or a lab report.

Subscribe now

Author bio

Dr Shiv Kumar Goel is a physician and functional medicine specialist based in San Antonio, Texas, who writes about the split between how people look on paper and how they actually feel. He practices at Prime Vitality Care and is the author of Healing the Split, a newsletter on symptoms, stories, and the quiet physiology of everyday life.

For three years I woke up at 3:40 in the morning. Not occasionally. Most nights, close enough to the same minute that I stopped looking at the clock, because looking made it worse.

I assumed it was age. I was in my mid-forties, I had a practice to run and a book in progress, and 3:40 felt like the invoice for that. Every physician I know has a version of this story, where we diagnose ourselves with something vague and move on, because the alternative is taking our own advice.

What it turned out to be had almost nothing to do with what I was doing at bedtime. It had to do with the four hours before it. I changed three things across that window and the 3:40 wake-up stopped. It has not come back.

I’m an internist, and I now ask every patient who tells me they can’t sleep to walk me through their evening rather than their bedtime routine. The answer is nearly always in the earlier part.

1. Moving the last meal earlier than felt reasonable

I used to eat at 8:30 or 9, because that’s when the day was actually over. Then I’d be in bed by 10:30 wondering why I felt warm and restless.

The study that reorganized my thinking here is a small, tightly controlled crossover trial out of Johns Hopkins, published in the Journal of Clinical Endocrinology and Metabolism in 2020. Twenty healthy young volunteers, ten men and ten women, spent two separate stays in a research unit eating the identical meal at either 6 PM or 10 PM, with a fixed 11 PM bedtime and blood drawn hourly through the night.

Same food. Same calories. Same people.

The late dinner produced a peak glucose roughly 18 percent higher, and overnight fat oxidation dropped by about 10 percent. Plasma cortisol went up. The effects were most pronounced in people who habitually went to bed earlier, which is to say the people for whom 10 PM was genuinely late relative to their own clock.

That’s a single meal, in healthy twenty-somethings, measured over one night. I want to be careful not to inflate it. But the authors’ framing is the part I quote to patients: if these effects recur chronically, they plausibly contribute to obesity and glucose dysregulation. Most of us are not eating one late dinner. We’re eating four hundred of them a year.

The mechanism also explains the 3:40 specifically. A large late meal drives a glucose rise and then a compensatory fall in the early hours, and that fall triggers a counter-regulatory cortisol and catecholamine response to pull blood sugar back up. That response wakes you. Separately, core body temperature has to drop for deep sleep to consolidate, and digestion is heat-producing work that runs directly against it.

I moved dinner to 6:30. Three hours before bed is the number I use with patients, and it produced the fastest effect of anything I changed. Not gradual. The first week.

The pushback is always about family schedules and about not being hungry at 6:30, and both are legitimate. When someone truly can’t move dinner, I tell them to move the size instead. A smaller late meal behaves differently than a large one. It’s not as good as an earlier one. It’s not nothing.

2. Cutting overhead light after sunset

This is the one that sounds like wellness theater. It is the best-evidenced item on the list.

Gooley and colleagues at Brigham and Women’s and Harvard published a study in the same journal in 2011 in which participants lived in a research center for at least five consecutive days under controlled lighting. Ordinary room light in the hours before bed, the kind in every kitchen in America, shortened the duration of melatonin production by roughly 90 minutes compared to dim light. Room light during habitual sleep hours suppressed melatonin by more than 50 percent.

Ninety minutes. From the ceiling.

The reason this happens is that melatonin release is gated by specialized retinal cells that care about intensity, wavelength, and crucially the angle light arrives from. Light coming from above, which is what every overhead fixture produces, reads to that system as midday sun.

I did not want to believe this mattered as much as it does. I put lamps at eye level and below in the rooms I actually use after dark, switched to warm bulbs, and stopped touching the overheads. My wind-down went from something I had to manufacture to something that arrived on its own around nine.

What I tell my patients: you don’t need candlelight. You need to stop being lit from above after sunset. It’s a lighting change, not a lifestyle change, and it costs about sixty dollars.

The screens matter too, but less than people assume and much less than the ceiling. A phone is a small light source six inches from your face. A kitchen ceiling is a large one filling your entire visual field.

3. The wind-down I resisted for years

Here’s the one I fought hardest.

I did not want an evening routine. It struck me as something for people with more time than I had, and there’s a version of it circulating now that’s so elaborate it becomes another job. If your wind-down has nine steps, you haven’t solved your sleep problem. You’ve given yourself homework.

What I eventually adopted takes twenty minutes and has two parts: I write down whatever is unfinished, on paper, in a list I don’t organize or prioritize. Then I read fiction.

The writing half has better evidence than I expected. Scullin’s group at Baylor published a polysomnography study in the Journal of Experimental Psychology in 2018 with fifty-seven adults who spent five minutes before bed writing either a to-do list for the coming days or a list of tasks already completed. The to-do list group fell asleep measurably faster. And the more specific and detailed the list, the faster they fell asleep, which is the opposite of what you’d predict if writing about unfinished work simply stirred up worry.

The interpretation the authors favor, and the one that matches my experience, is offloading. The tasks don’t get done. The brain stops rehearsing them because they’ve been externalized somewhere reliable.

It’s fifty-seven young adults on a single night in a lab, so I hold it loosely. But it costs five minutes and a piece of paper, and I’ve now watched enough patients report the same thing that I ask about it routinely.

The fiction half has no trial behind it and I won’t pretend otherwise. It’s a boundary. I needed something my mind could not usefully continue at three in the morning, and medical journals failed that test badly.

What didn’t work, despite the hype

I want to name what I tried first, because I spent money and about eighteen months before I addressed anything above.

Melatonin supplements did essentially nothing for me, and in hindsight that’s unsurprising. Meta-analyses of melatonin for sleep onset show a genuine but small effect, on the order of several minutes. My problem was not a melatonin deficiency. It was a melatonin timing problem, created at 7 PM by my kitchen ceiling, and a three milligram tablet at 10 PM does not fix a signal that was already scrambled.

A sleep tracker made things actively worse for a while. There’s a recognized phenomenon here, named orthosomnia by Baron and colleagues in 2017, in which the pursuit of perfect tracked sleep produces the anxiety that then degrades sleep. I became a person who woke and immediately checked a score, and on nights the score was poor I felt worse than the sleep itself warranted. I took a two-month break from the ring and slept better during it.

Magnesium helped a little. I still take it. It’s a modest assist on top of a fixed foundation, and I had the order backward for a year and a half.

Start with the earliest one

If you change one thing, change the earliest one in the day.

That’s the principle I’ve landed on. Evening problems compound forward. A late meal makes the light exposure matter more, and both make the wind-down harder, and by the time you’re lying in bed doing breathing exercises, you are trying to solve at 10:45 a problem that was created at 6:30.

So move dinner. Not by three hours, not perfectly, not every night. Move it ninety minutes for two weeks and watch whether the hour you keep waking at changes.

Mine moved to 5:15, which was still annoying. And then it stopped.

If the four hours before bed are quietly breaking your sleep, you’re not alone. In this essay I walk through three small evening changes—earlier dinner, dimmer light, and a paper wind-down—that stopped a 3:40 a.m. wake-up that had followed me for years

Dr Shiv Kumar Goel is a board-certified internist practicing functional and integrative medicine at Prime Vitality Care in San Antonio, Texas. Follow his Substack, healingthesplit, for more of his writings.

References

• Gu C, Brereton N, Schweitzer A, et al. Metabolic effects of late dinner in healthy volunteers: a randomized crossover clinical trial. J Clin Endocrinol Metab. 2020;105(8):2789–2802.

• Gooley JJ, Chamberlain K, Smith KA, et al. Exposure to room light before bedtime suppresses melatonin onset and shortens melatonin duration in humans. J Clin Endocrinol Metab. 2011;96(3):E463-E472.

• Scullin MK, Krueger ML, Ballard HK, Pruett N, Bliwise DL. The effects of bedtime writing on difficulty falling asleep: a polysomnographic study comparing to-do lists and completed activity lists. J Exp Psychol Gen. 2018;147(1):139–146.

• Baron KG, Abbott S, Jao N, Manalo N, Mullen R. Orthosomnia: are some patients taking the quantified self too far? J Clin Sleep Med. 2017;13(2):351–354.

She did not book an appointment to talk about her life.
She booked it for peptide therapy.

Reverse the aging. Fix the joints. Optimize the labs.
She arrived with that specific, polished ask, the way high‑functioning patients often do.

She had done her research — PubMed, blogs, podcasts, all cross‑indexed in her mind.
She could quote trials, list side effects, and explain mechanisms of action more fluently than some residents I’ve trained.

Halfway through her intake, she mentioned the zoledronic acid.

“Mild osteoporosis,” she said. “Some side effects.”
Her tone was flat, as if she were reading from someone else’s chart.

I wrote it down, but not because of the bones.

When someone accepts that much pharmaceutical intervention for that little disease burden, it is almost never about the T‑score.

She did not bring a physical folder into the room.
Her folder was internal — tabs already color‑coded.

Insomnia.
Anxiety.
Always at the edge.
The pressure to look perfect.

She named each item with the precision of a cardiologist calling out EKG leads: V1, V2, V3 — except her leads were dermatology, endocrinology, OB‑GYN, psychiatry, and therapy.

She had five different clinicians, each holding one sliver of the same nervous system.
Five separate conversations about five separate pieces of the same person.

“I’m probably a carbon copy of my mother,” she said.
Then, almost in the same breath: “We haven’t spoken in a while.”

No catch in her voice. No softening.
Just the report: an emotional biopsy that had long since been fixed in paraffin and labeled “old news.”

Her mother was anxious, always on the edge, the way she is now.
The same hypervigilant wiring passed down like eye color, except no one ever named it as inheritance.

Her father “was there,” she said, “we’re just not that close.”
Again, six words, zero affect.

Her children now live in different states.
She is single.
The pattern is clear from the outside; it had not yet broken through from the inside.

She spoke in full paragraphs.

No hesitations. No searching for language.
She anticipated my questions and answered them before I could open my mouth.
She knew the clinical vocabulary, the generational thread, the HPA axis, and the word “epigenetic.”

She knew everything.

And somewhere in the telling and retelling of her life, she had stopped actually hearing herself.

Sitting in that exam room, I noticed something I rarely name explicitly:
There was no silence.

Not one pause she did not immediately fill.
Not one question she allowed to hang unanswered for more than a second.
She was talking faster than the silence could catch up.

This is a gap medicine does not have billing codes for.

It is not the gap between symptoms and diagnosis.
It is not even the gap between subjective distress and “normal” labs.

It is the gap between accurate self‑knowledge and actual change.

She could map the inheritance two, three generations back.
She understood what chronic vigilance does to cortisol, sleep architecture, and connective tissue.
She had the map.

But knowing the biography is not the same as rewriting it.

The body does not keep score of what we understand.
It keeps score of what we allow ourselves to feel.

From a purely medical standpoint, I could have stayed on the surface.

Order labs.
Adjust hormones.
Optimize peptides.
Tighten up her supplement stack.

And I did some of that.

I reviewed her zoledronic acid history and told her — gently — that in my view it was more intervention than her bone density warranted.
We sketched out a reasonable plan for peptide therapy, acknowledging both the benefits and the limits.

But the more important intervention was upstream.

She did not need another molecule before she had at least one room in her life where she could stop performing the knowing.
One room where her job was not to present the polished, coherent narrative of her suffering — but to risk the awkward, disrupted silence of actually feeling it.

I asked her one question no one had asked her before.
I am still not sure if she heard it.

On paper, the plan she left with looked a lot like what she had received before: labs, follow‑up, therapeutic options.
The difference was not in the complexity of the protocol.
It was in the question underneath.

Do you want to keep narrating this life from just above it, or are you willing to come down into the body that is paying for it?

Because here is the quiet truth we rarely say out loud in clinic:

Insight is not always the door.
Sometimes insight is the lock.

As physicians, we have built exquisite tools for naming what is wrong — imaging sequences that see millimeters, biomarkers that measure nanograms, pharmacology that targets receptors with surgical precision.
We have far less training for what to do when a patient already knows exactly what is wrong and uses that knowing to stay exactly where they are.

We say, “Can’t help someone who doesn’t want to be helped.”
But she kept making appointments. She kept walking through doors.

People who have truly stopped looking do not do that.

So this is not a story about a “noncompliant” patient.
It is a story about sequence — about what happens when we jump to the molecule before we sit with the silence.

For the patient who recognizes themselves in her:

If you have told your story to multiple clinicians, multiple therapists, multiple friends, and nothing in your life has moved, the problem may not be that no one is listening.
It may be that you have learned to talk just fast enough to stay ahead of the silence that terrifies you.

The work is not to explain your life better.
The work is to risk one room — with a clinician, a therapist, a trusted witness, or even with yourself — where you stop explaining and let your body answer back.

All identifying details in this case have been modified.

Dr Shiv Kumar Goel is a physician writer and functional medicine specialist exploring where biology, story, and silence meet. He works at the intersection of longevity, trauma‑informed care, and the quiet ways the body keeps score.

She came for peptide therapy.

That was the request. Reverse the aging. Fix the joints. She had done her research — the way she did everything — thoroughly, fluently, with full command of the literature.

She mentioned the zoledronic acid almost in passing. Mild osteoporosis, she said. Some side effects. She said it the way she said everything. Like a fact that had already been processed, already filed.

I wrote it down.

Because when someone accepts that much intervention for that little disease, the question is almost never about the bones.

She came in with a folder.

Not a physical folder. The folder was in her mind. Every tab labeled. Every section indexed.

Insomnia. Anxiety. Always at the edge. The need to look perfect. She named them the way a cardiologist names leads on an EKG — precisely, without flinching.

She had an OB-GYN, a dermatologist, a PCP, an endocrinologist, and a therapist. Five physicians. Five separate conversations about five separate pieces of the same person.

She had done the work. She had read the chapters. She had named the inheritance.

“I’m probably a carbon copy of my mother,” she said. Then, almost in the same breath: “We haven’t spoken in a while.”

She said it flat. Not grieving. Not angry. Reported.

The way you report a fact you stopped feeling a long time ago.

The mother was not easy. Anxious. Always at the edge — the same edge. The same nervous system, passed forward without anyone choosing to pass it.

The father was there. Physically. But not really there.

She described him in six words: “Yeah, we are just not that close.”

No catch in her voice. No pause. Just the flat geography of a distance she had stopped trying to cross.

She is single now. Her children live in different states.

She knew the pattern. She just hadn’t let it touch her yet.

She talked in full paragraphs.

No searching for words. No visible confusion. She anticipated questions and answered them before I could ask. She knew the clinical language. She knew the generational thread. She knew what the body does when it grows up inside a nervous system that never learned to rest.

She knew everything.

And somewhere in the telling and the telling and the telling, she had stopped hearing it herself.

I felt it clearly in that room. She had been telling her story to everyone. But not really hearing it deeply enough to understand.

That is what I sat with.

The story was not the problem. The story was correct. The problem was that the story had become the container — and the container had become the limit.

She was narrating her life from just far enough above it that she could not feel the ground.

I noticed something I rarely notice. There was no silence in that room. Not one pause she didn’t immediately fill. Not one question she left open.

She was talking faster than the silence.

And I did not know — sitting there — if she would ever let one in.

This is the gap medicine almost never names.

Not the gap between symptoms and diagnosis. Not the gap between what a patient feels and what the labs show.

The gap between accurate self-knowledge and actual change.

She could narrate the inheritance. She could trace it one generation back, two generations back. She knew the word epigenetic. She understood what chronic vigilance does to the HPA axis. She had the map.

Your symptoms are not random. They are your biography written in your biology.

But knowing the biography is not the same as rewriting it.

The body doesn’t keep score of what you understand. It keeps score of what you feel.

I want to be honest about the peptide request.

I prescribe these therapies. I use some of them myself. They are real molecules with real biology. This is not a story about a patient who was wrong to ask.

It is a story about sequence.

She wanted to reverse age. Fix the joints. Restore the surface. She had already done this with everything else — a specialist for each piece, a molecule for each complaint, a framework for each pattern.

Each piece in its own box. Each box handled. None of them adding up to a person who could sit in a quiet room without filling it.

She did not need another molecule before she had one room in her life where she could stop performing the knowing.

That was the upstream. And the upstream is always where the answer lives.

I did not tell her this in those words.

I ordered labs. I reviewed the zoledronic acid — it was, in my view, more intervention than her bone density warranted, and I said so carefully. I asked one question she had not been asked before. I do not know if she heard it.

She left with a plan. It looked, on the surface, like most of what she had been given before. The difference was not in the complexity.

It was in the question underneath.

Can’t help the one who doesn’t want to be helped. I have felt that before. But she came. She kept making appointments. She is still walking through doors.

People who have truly stopped looking do not do that.

I want to say something to the physicians reading this.

We have built extraordinary tools for naming what is wrong. Better imaging. Smarter biomarkers. More precise pharmacology. We have almost no practice for what to do when a patient already knows what is wrong — and has learned to use that knowing to stay exactly where they are.

Insight is not always the door. Sometimes insight is the lock.

And for the reader who sees themselves in her:

If you have told your story many times and nothing has changed, the problem may not be that no one is listening.

It may be that you have learned to talk just fast enough to stay ahead of the silence.

The work is not to explain your life better.

It is to risk one room where you stop explaining — and let your body answer back.

All identifying details have been modified.

Dr. Shiv Kumar Goel is a board-certified physician practicing internal, functional, and aesthetic medicine in San Antonio, Texas. He is the founder of Prime Vitality Care. He is the author of the forthcoming book Healing the Split: When Your Biology Is Fighting Your Biography, hosts the Healing the Split podcast, and writes the Healing the Split Substack at healingthesplit.com. His work appears in KevinMD, Op-Med, Medium, Elephant Journal, and San Antonio Medicine.

Subscribe now

We’ve spent a century learning how to live longer. The harder question is how slowly we can age.

She was thirty-four. She had run a half-marathon the spring before. She ate the way the magazines tell you to, and her intake form had nothing worth circling. She came in for a few weeks of symptoms she’d filed under stress. The colonoscopy said otherwise. (PATIENT — COMPOSITE, all identifying details modified; no single real patient is depicted.)

She was, by every metric, fine. That is the part I keep returning to.

Two decades ago, a chart like hers would have stopped a hallway full of clinicians. We’d have called it a fluke and moved on. The diagnosis still lands like a blow. But it no longer surprises me the way it once did, and that shift — from unthinkable to ordinary — happened inside a single career. Mine. It leaves a question I can’t put down. If our genes haven’t changed in a generation, why are the diseases of old age arriving early?

The number on the cake isn’t the number that matters

There are two ways to count a life. The first is easy. The candles. The count of birthdays. Chronological age is honest but shallow. It tells you how many times the earth has circled the sun while you were alive. It tells you nothing about the body that did the orbiting.

The second count is biological age. How worn or how resilient your cells and systems actually are, after years of absorbing your genetics, your habits, your environment, and a thousand exposures you never noticed. Two people can blow out fifty candles on the same afternoon and live in entirely different bodies. One carries the physiology of a younger person. The other is already weathered.

This is the gap I have spent twenty years inside. Good labs. Bad life. There’s a reason. The cake doesn’t know the difference. Increasingly, the science does.

What the evidence shows, and what it doesn’t

A study published this June in Nature Medicine sharpens the intuition. Researchers at Washington University drew on 154,169 adults in the UK Biobank, with validation in a separate US cohort, and measured biological aging with a clock called PhenoAge. People born in more recent decades aged faster than those born earlier. Those born between 1965 and 1974 carried a biological age gap roughly 23% higher than people born in the early 1950s. And a faster pace of aging tracked with solid cancers diagnosed before fifty-five — driven by lung, gastrointestinal, and uterine cancers.

The detail that holds me is organ-specific. When they looked tissue by tissue, an aging immune system tracked with early-onset lung cancer, and an aging adipose system — the body’s fat tissue — tracked with early-onset colorectal cancer. Not the whole body aging at once. A particular system, escalating ahead of the rest.

It’s worth being precise here, because precision is where most health writing gets lazy. This is an association, not a verdict. The study does not prove accelerated aging causes cancer. It shows the two travel together, and the effect, per standard deviation, is modest. “Biological age” isn’t one thing either. It’s a family of clocks, and they don’t agree. This one leaned on PhenoAge, built to predict mortality and clinical risk rather than just birthdays, and confirmed the signal with two independent measures. Knowing which ruler was used is the difference between a finding and a feeling.

Still, associations are how medicine finds its way. They tell us where to dig. This one points somewhere uncomfortable.

Progress arrives with a hidden invoice

The study doesn’t hand us a villain. No single toxin to ban. No one gene to blame. Accelerated aging looks instead like the sum of small, patient pressures. Chronic inflammation, broken sleep, processed food eaten at all hours. The long sit, the ambient dread, the disrupted gut. Each one is modest. In aggregate they are the slow accumulation of small inflammations that I have watched age people, biomarker by biomarker, year by year.

None of this is new. What’s new is how thoroughly it’s been woven into ordinary life. Every advance that made living easier also made it easier to sit still, sleep badly, and eat from a wrapper. Progress arrives with a hidden invoice. The convenience is charged to the body, and the bill comes due quietly, years before anyone reads it aloud in an exam room.

Here is where I refuse the easy story

This is the moment the wellness economy steps in with its list. Move more. Eat real food. Sleep. Drink less. Manage your stress. The list is not wrong. I use a version of it in my own practice, on my own body.

But it’s also where the wellness industry cheats, and where medicine fails the same patient from the other side. The industry sells the list as willpower, in fourteen-day and thirty-day cycles, as if biology kept a calendar. Medicine, meanwhile, waits downstream, treating the diagnosis once it arrives and rarely asking what upstream let it.

My half-marathoner had already done the list. She was hyper-compliant, with the wrong map. Every number anyone routinely checks came back reassuring — her weight, her glucose, her HbA1c. But her fasting insulin was 22. Her hsCRP wouldn’t settle. Her cortisol, low in the morning the way it should be, refused to come down at night. When I asked about her gut, she said no. Then, almost as an afterthought: just some episodic diarrhea and acidity, lifestyle and her periods, she guessed. None of it was a diagnosis. All of it was a body escalating.

The wellness version would have told her to try harder. The conventional version told her she was fine, until she wasn’t. She didn’t need more discipline. She needed someone to take both her normal labs and her wrong instinct seriously at the same time. That is the work. Not picking a team. Finding out what is actually happening inside this specific person.

The clock is not the calendar

Here is the hinge the whole story turns on. Biological age, unlike the candle count, is not fixed. The processes that drive it are responsive — to movement, to real food, to restorative sleep, to less alcohol, to managed stress. Not as moral instructions. As levers that move many systems at once.

They don’t merely lower the odds of one disease. They appear to slow the accumulation of damage itself. And for the first time we can begin to measure it. Newer clocks, like one called DunedinPACE, were built precisely to track the pace of aging as it responds to how a person lives. I can watch a fasting insulin of 22 come down, an hsCRP settle, a cortisol curve learn to fall again at night. That turns vague worry into something a patient can see. What people can see, they can change.

The question for the century

So I find myself less interested in the old triumph than in the new task. Medicine got extraordinarily good at the first job. Keeping people alive longer. We added the years. The harder, less photogenic work now is making sure those years are lived in a younger body.

If younger generations really are aging faster than their parents, then the defining health question of this century is no longer how long we can live. It’s quieter than that. How slowly can we age — and are we willing to read the hidden invoice before it’s too expensive to pay?

I think back to my thirty-four-year-old. The lesson of her chart wasn’t despair. It was urgency, and a strange consolation. The clock we’re worried about is one we can still, in part, slow down. Her biology was fighting her biography. The candles never knew.

Primary source: Tian et al., “Biological aging and generational shifts in early-onset cancer risk,” Nature Medicine (2026), doi:10.1038/s41591-026-04448-w. Supporting work: Belsky et al., “DunedinPACE,” eLife (2022); Sylvester/University of Miami research on biological age acceleration and colorectal polyps in adults under 50 (Cancer Prevention Research, 2024).

Dr. Shiv Kumar Goel, MD, is a board-certified internal and functional medicine physician in San Antonio, founder of Prime Vitality Care, host of the Healing the Split podcast, and author of the forthcoming Healing the Split. He writes on the body-mind-consciousness frontier of modern medicine.

I have always laid my cards down flat.

Every one of them. Face up. Nothing tucked away in a sleeve, no strategy, no performance. Just the full hand — spread wide across the table for anyone willing to look.

And yet.

They squint. They hesitate. They circle slowly, convinced there must be a trick somewhere. Because surely, no one is this open. Surely, transparency this complete must be concealing something.

So they lean in and begin to read.

But not my cards. Their own.

Every line they trace is a fear they never named out loud. Every meaning they extract is a story they have been carrying — pressed tight against their own chest, never shown to anyone. They read their secrets and call them mine. They hear their own voice and think it is my confession.

I was not bluffing. I was simply the only one at the table who stopped pretending.

I am an open book — always have been. Every page turned, every chapter bare. No locked rooms, no torn-out entries, no careful editing of the parts that do not look good in daylight.

So why does no one read me?

The ones who try — they skim. They scan for what they already expect to find, recognize the familiar, skip the rest, and call it understanding. They do not read my words. They read their own translation of them — filtered through their fears, their projections, their unresolved stories — and hand it back to me as if it is mine.

This, I have come to understand, is the cruelest irony of openness.

You lay everything down and discover that most people do not know how to read something that is not written in their own language. Transparency is not enough. It never was. The reader has to be willing to set down their own story long enough to receive yours.

Most are not willing.

She came in with everything already organized.

Every symptom dated. Every prior diagnosis labeled. Every medication, every reaction, every physician she had seen over fourteen years — laid out in a document she had written herself, printed and brought to the appointment.

Fourteen years. Eleven physicians.

She had been transparent with every one of them. More than transparent. She had done the work most patients never do. She had named the pattern before anyone asked. She had connected the fatigue to the insomnia, the insomnia to the anxiety, the anxiety to the year her mother died, and the year her mother died to the decade that followed — the one she described as living at half-volume.

Nobody had slowed down long enough to receive it.

They read the labs. They adjusted the medications. They treated each complaint as its own event — a separate chapter in a book they never bothered to open.

One physician told her she was too focused on her symptoms. Another told her the anxiety was driving everything. A third ordered more tests and never followed up.

She was not complicated. She was clear. She had done the translation for them. She had handed them the map, labeled and legible, and they had filed it away and looked instead for what they already knew how to find.

What it cost her was fourteen years. And a particular kind of exhaustion that is different from tiredness — the exhaustion of being present, fully available, and still invisible.

What changed when I slowed down was this: I read what she actually wrote.

Not the labs. The document. Her document. The one she had brought to eleven appointments before mine.

I asked two questions nobody had asked. She answered in one sentence each. We sat with both answers for a moment.

She said: Nobody has ever just let it sit there before.

I said: I know.

All identifying details have been modified.

I have sat with hundreds of people in their most vulnerable moments. And I have noticed something quietly devastating. The most transparent people in the room are often the most misunderstood.

Not because they are complicated.

Because depth requires the reader to slow down. To set aside their own narrative for a moment. To actually listen, rather than interpret.

Most people never do.

They are too busy holding their own deck tightly against their chest — reading their hidden cards so loud inside their own heads that they mistake their own reflection for someone else’s truth.

Your symptoms are not random. They are your biography written in your biology.

The first failure — before any lab, before any scan — is often this: no one actually read the book the patient laid open on the table.

There is a particular kind of loneliness that belongs only to the truly open.

It is not the loneliness of isolation. It is worse.

It is the loneliness of presence — of being right there, fully available, wide open — and watching people look straight through you. Or worse, look at you and see only themselves.

I know this loneliness from inside the clinic. I know it from inside my own life.

The split between who you are and how you are received — that is a real fracture. It accumulates slowly, quietly, in the way that small inflammations accumulate over years before they finally become something a test can measure.

The body does not malfunction. It escalates.

And so does the silence around the person no one learned to read.

This is why I write.

Not because writing guarantees being understood. It does not.

But because the page receives what people often cannot. It holds exactly what you give it. It does not translate, filter, or hand it back misread. The words stay where you put them. They do not rearrange themselves into someone else’s story while you are not looking.

Writing does not misunderstand you.

And maybe that is enough — to be witnessed, even if only by yourself. To name the thing. To lay the card down. To say this is real, this happened, this is who I am — and let it exist somewhere outside the silence.

Write it down.

Dr. Shiv Kumar Goel, MD, FACP, is a board-certified internal and functional medicine physician in San Antonio, founder of Prime Vitality Wellness®, host of the Healing the Split podcast, and author of the forthcoming Healing the Split: When Your Biology Is Fighting Your Biography. He writes at healingthesplit.com.

Subscribe now

She used the word failure the way some patients use the word diagnosis—as if someone with more authority had already confirmed it. She had lost forty pounds on Ozempic. She regained all of it in eleven months, the same month her insurance stopped covering the prescription.

She didn’t say her coverage lapsed.
She said she failed.

I didn’t correct her right away. Corrections land differently when someone finally hears themselves say the wrong thing out loud, in a room where another human being is prepared to disagree.

This is not an argument against the drug. Ozempic, Wegovy, Mounjaro—GLP‑1 receptor agonists—are among the most effective tools medicine has produced in decades. I prescribe them often. I will continue prescribing them.

The molecule is not the problem.
The problem is everything we never built around it.

The Silence No One Warned Her About

On paper, she did exactly what the drug is designed to do. GLP‑1 agonists act on receptors in the hypothalamus and hindbrain—the regions that register fullness and food reward long before conscious willpower gets a vote.

Her labs were pristine. Fasting glucose, A1c, lipids—textbook. The scale moved forty pounds in the right direction. By every metric medicine is trained to track, this was a success story.

But her labs never captured what stopped the moment the drug started working.

For eleven months, she told me, the noise went quiet. She used that word before I did. The constant negotiation over when she’d eat next. The low hum of food thoughts she’d carried since her twenties. Gone.

She didn’t miss the forty pounds nearly as much as she missed the silence.

She is not the only patient who has credited this drug for a quiet it never explained.

The Weight We Don’t Measure

A man in my practice lost forty pounds in five months. He celebrated the number before he came back to see me. A quarter of that weight was muscle.

No one had measured his muscle mass before he started, so no one could tell him what he was trading away while the scale kept dropping. When I finally checked his body composition and showed him the split between what he lost and what he thought he lost, he went quiet in a different way.

“I thought I was getting healthier the whole time,” he said.

He had gotten thinner.
Those are not always the same sentence.

Muscle is not vanity tissue. It determines how well he will walk at seventy, how well he clears glucose at fifty, whether a fall at eighty ends in a bruise or a fracture. Losing a quarter of forty pounds as muscle is not a cosmetic footnote. It is a silent decision—made by a drug and an unmonitored deficit—about what kind of body he will inhabit in twenty years.

A decision no one asked him to make.

The Appetite That Disappears Too Well

Another patient has not eaten enough protein in eight months to maintain the body she has left. No one told her that appetite suppression this strong requires a deliberate plan to eat against it—not simply less of everything.

She does not lack discipline.
She lacks a target no one gave her, for a problem no one named.

The drug changes what the body is asking for today.
It does not tell you what the body was asking for the thirty years before that.

That is the split.
Good labs. Bad life. And there’s a reason.

What Food Noise Was Doing All Along

Food noise that runs for decades does not appear out of nowhere. Somewhere in that span, it was doing something—regulating a low-grade anxiety that had nowhere else to go, filling a specific kind of evening silence, giving a pair of hands something to manage while a marriage, a job, a grief needed managing and food was the only variable within reach.

The receptors GLP‑1 drugs quiet are neighbors to the brain’s reward circuitry. Appetite and dopamine-linked craving share real estate. Turning down one can turn down the other. For a while, that feels like relief instead of erasure.

But quieting a signal chemically is not the same as resolving whatever built it over thirty years. The signal returns the moment the chemistry stops.

It returned for her at month eleven, when her coverage lapsed and the noise came back like a light switch—and she mistook a gap in her insurance plan for a moral failure.

She wasn’t confused.
She was reading the only explanation anyone had offered her, which was none.

What Changes When We Treat This as Data

When clinicians take this seriously—not as a footnote but as data—the prescription doesn’t change. Everything around it does.

It starts with a body composition scan, not just a weight, so muscle has a number attached to it before anything is lost—a number that can be defended later instead of guessed at.

It continues with a protein target that sounds almost aggressive, delivered on day one, because appetite has been flattened and eating on purpose now takes effort the drug was supposed to remove.

It includes a direct conversation about resistance training—not as an aesthetic add-on, but as the only intervention that tells the body which tissue to keep while the deficit runs.

And it means asking, before the drug ever starts, a question most intake forms don’t have a field for:

What has this noise been doing for you—and what do you expect to feel in the week it goes quiet?

Some patients answer immediately.
Some need a minute.
Either way, the answer belongs in the chart, not the margins.

It also means saying the uncomfortable part out loud at the first visit, not the eleventh: this drug is expensive, coverage is unstable, and if it lapses, the body does not gently return to baseline. It defends the weight it lost, and it defends it hard.

A plan for that month should exist before that month arrives—not be improvised inside it, in a patient’s private verdict that she is the one who failed.

The Plan Was the Problem

None of this is a cure. It isn’t even a protocol. It is a different way of looking at the same drug.

The prescription doesn’t change.
What surrounds it does.

She is back on the medication now, through a different channel. The forty pounds are coming off again—more slowly this time, with a protein target and a scale that measures more than weight.

Nothing about her chemistry changed between the first round and this one.

What changed was the question I asked before writing the prescription.

She was not the failure.
The plan was.

Follow a physician-led exploration of the hungers we don’t talk about—metabolic, emotional, and existential. Subscribe for clinical stories and tools that actually help

Subscribe now

More From Healing The Split: Life Beyond Labs Series

• Life Beyond Labs: What Your Doctor Missed (But Your Body Didn’t)

• Your Doctor Doesn’t Know What Your Grandmother Already Did

• The Ledger of Everything Unsaid

• A Body Scan for the Ones Who Live in Their Heads

• I’m an MD. Her Leaky Gut Wasn’t a Gut Problem — It Was a Life Problem.

Dr. Shiv Kumar Goel is a board-certified physician and writer specializing in Internal, Functional, and Aesthetic Medicine. As the founder of Prime Vitality Wellness in San Antonio, Texas, he practices a holistic, patient-centered approach that blends cutting-edge clinical medicine with ancient wisdom and integrative healing. His essays and op-eds have appeared in Doximity’s Op-Med, and he writes regularly on Substack (Healing the Split) and Medium.

Dr. Goel believes that medicine at its best is an act of recognition — helping patients return not just to health, but to themselves. He lives and practices in San Antonio, Texas.

All names and identifying information have been modified to protect patient privacy.

You have been told, “It’s life.”
“Stop overthinking.”
“It’s all in your head.”
“You’re just hormonal.”
“You’re fine.”

You try to believe it.

You go back to work. You keep the house moving. You push through the mornings that feel heavier than they should. You explain away the gut that turns unpredictable, the pain that moves, the sleep that breaks at 3 a.m., the edge in your mood that does not feel like you.

Then the part of you that has been quiet the longest speaks up.

You notice that the fatigue no longer responds to sleep. That the “just stress” headache has become a weekly appointment. That you are living inside a body you do not quite recognize, with symptoms you can list and a story you cannot quite tell.

So you do what you are supposed to do.

You see a doctor. You get the labs. You wait for the answer.

They come back normal.

“Everything looks good.”
“You’re fine.”

On the printout, this is good news. In your chest, it does not feel that way.

Because when your life has been quietly deteriorating, a normal result can sound less like reassurance and more like erasure. The numbers did not explain you. They seemed to erase you.

I am a board-certified internist. I have been practicing medicine for more than twenty years. I have ordered the panels that told patients they were “fine.” I have watched the small collapse in the face across from me when I said those words to someone whose body had been telling a different story for a long time.

I know what our current tools are designed to do. They are excellent at finding clear-cut disease — the tumor, the infarct, the infection, the crisis that must not be missed. They are not designed to detect what happens to a human body that has been living in prolonged stress, misalignment, or grief for years. That is not a failure of effort. It is a failure of frame.

That gap is what this essay is about.

For most of my career, I did what I was trained to do. I treated the fragment in front of me. The right medication. The correct referral. The appropriate workup. I was good at it. I was also, quietly missing something — the same thing I kept watching my patients miss, even when I handed them results that were technically reassuring.

The question that eventually changed my practice was not a clinical question.

It was this:

What if the body is not malfunctioning? What if it is escalating?

A whisper before it screams. A tightening of the jaw. A shift in sleep by thirty minutes. A gut that stops being predictable. A fatigue that is heavier than the day should have earned. A pain that migrates, returns, resolves, returns again.

We are trained to call this being stressed. Being anxious. Being too sensitive. Being a little run down.

What we are less trained to call it is what it often is:

A body telling the truth about a life that has stopped being heard.

A CBC cannot tell you whether your body has been bracing for twenty years.
A metabolic panel cannot tell you whether you learned in childhood that rest was dangerous.
A thyroid result cannot tell you whether your nervous system equates stillness with threat.
An inflammatory marker cannot always reveal the daily cost of swallowing grief, living in a relationship where your body never relaxes, or performing competence while slowly disappearing from yourself. verywellhealth+1

This does not mean those tests are useless.

It means they are incomplete.

The body is not divided into the same departments as the medical system. It does not separate cardiology from psychology, gastroenterology from grief, endocrinology from identity, immunology from loneliness, metabolism from meaning.

The body receives the whole life.

And it responds as one system.

This is not a rejection of medicine. It is an argument for asking more of it, not less.

The research already exists. Psychoneuroimmunology has mapped how chronic stress reshapes immune signaling. Circadian biology has shown that misaligned sleep timing keeps the body in a low-grade emergency even when total hours look adequate. The gut-immune axis has revealed how the microbiome influences inflammation, mood, and cognition. Trauma physiology has documented how early adverse experience resets the HPA axis decades later. The biology of meaning — purpose, connection, belonging — is now measurable in stress hormones, inflammatory markers, and health behavior adherence.

None of this is soft. All of it is biology.

The problem is not that the science is missing. The problem is that our clinical workflow still behaves as if a person’s marriage, grief, childhood adaptation, loneliness, work climate, and loss of purpose are separate from the panel.

They are not separate from the panel. They are what the panel is often silently measuring.

If you have ever driven home from a doctor’s appointment with a clean report and the quiet, disorienting sense that something has still been missed — you are not imagining it.

You may be living inside a pattern that has not yet been read.

That is not the same as being broken.

It is the beginning of a different question.

The labs can rule out many things. They cannot prove that a life is metabolizing safely inside a human body. That question — the one medicine has not yet built an instrument for — is worth asking.

The body is not random.

It is reporting.

And when medicine only measures the physical fragment, the whole pattern disappears.

This essay begins Life Beyond Labs: What Your Doctor Missed (But Your Body Didn’t) — a series for anyone who has ever walked out of an appointment with “normal” results and the quiet certainty that something important was still unread.

Dr. Shiv Kumar Goel is a board-certified internist and founder of Prime Vitality Care in San Antonio, Texas. He writes about the gap between normal lab results and persistent patient suffering. His forthcoming book is Healing the Split: When Your Biology Is Fighting Your Biography.

Everything I publish here stays free. That does not change.

But a few of you have asked how to support the work. So I turned that on.

You can now support the work as a paid or founding member. Nothing is locked behind it.

Here is what your support pays for. Time to write honestly. Cases rendered with care. A book, Healing the Split, being finished now.

Good labs. Bad life. There’s a reason. That sentence has found a lot of you. I want to keep chasing it.

If the work has meant something, you can back it below. If not, keep reading for free. Both are welcome.

Founding members get early chapters of the book, first access to what I build next, and my thanks by name.

Thank you for being here.

Shiv